$CRBP
Corbus Pharmaceuticals Holdings, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Corbus Pharmaceuticals Holdings, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is CRBP down today? It is at $2.09 (-15.40%), and our scanner flagged it 115 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CRBP spikes, and full due diligence on CRBP — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CRBP 115 times in the last 30 days. Create a free account to track $CRBP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how CRBP traded in the last session, Friday (last price and move above). Our scanner fired 23 unusual-volume and momentum alerts on CRBP on Friday, peaking at 27.6x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystCorbus Pharmaceuticals presents Phase 1b CANYON-1 clinical trial data for CRB-913 at ObesityWeek® 2026Reported CRB-913 demonstrated statistically significant and clinically meaningful mean weight loss of 5% at 60 mg after 12 weeks with no plateauing observedReported LS mean weight loss from baseline at week 12, %1Reported LS mean weight loss at week 12, % (placebo-adjusted)1, from the latest SEC filing. Read it →Across every filing on file, supply equal to 12688.5% of the tradeable float is in play - 12688.5% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
13,563,830 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $127.5M in size · Priced at $9.4/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Cormorant Asset Management, Lp Other | Sold (automatic/other) | -425K 2.1% of company | sold 18% | 1.92M | $1.7M at $4.10 | Oct 29, 26 |
Ben Yong Director | Sold (automatic/other) | -2K | sold 18% | 9K | $16K at $7.84 | Sep 14, 26 |
Nicacio Leonardo Viana Officer | Acquired (grant/award) | +58K 0.3% of company | n/a | 58K | n/a | Aug 16, 26 |
Saxena Nishant C Officer | Bought (open market) | +3K 0.01% of company | added 3.5% | 78K | $25K at $9.63 | Aug 11, 26 |
Moran Sean F. Officer | Sold (automatic/other) | -12K 0.06% of company | sold 12% | 85K | $121K at $10.08 | Aug 7, 26 |
Cohen Yuval Officer | Sold (automatic/other) | -17K 0.08% of company | sold 9.8% | 157K | $171K at $10.08 | Aug 7, 26 |
Jenkins John Kenneth Director | Sold (automatic/other) | -5K 0.02% of company | sold 56% | 4K | $38K at $7.91 | Jun 10, 26 |
Altmeyer Anne Director | Sold (automatic/other) | -2K 0.01% of company | sold 24% | 8K | $19K at $7.91 | Jun 10, 26 |
Kung Winston Director | Sold (automatic/other) | -2K | sold 14% | 12K | $16K at $7.91 | Jun 10, 26 |
Saxena Nishant C Officer | Bought (open market) | +9K 0.04% of company | added 14% | 75K | $68K at $7.58 | Jun 3, 26 |
Saxena Nishant C Officer | Bought (open market) | +5K 0.02% of company | added 7.3% | 66K | $33K at $7.33 | Jun 2, 26 |
Saxena Nishant C Officer | Acquired (grant/award) | +58K 0.3% of company | added 100% | 62K | n/a | May 21, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how CRBP traded in the last session, Friday (last price and move above). Our scanner fired 23 unusual-volume and momentum alerts on CRBP on Friday, peaking at 27.6x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
CRBP last traded at $2.09, down 15.40% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The CRBP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CRBP 115 times in the last 30 days.
CRBP (Corbus Pharmaceuticals Holdings, Inc.) trades on XNAS, with a market cap of about $42M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CRBP for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CRBP discussion
Sign in to ask a question or join the discussion.